• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study.

作者信息

Barni Sandro, Livraghi Luca, Gravina Adriano, Martella Francesca, D'Onofrio Loretta, Morritti Maria, Michelotti Andrea, Vici Patrizia, Mentuccia Lucia, Porcu Luca, Orditura Michele, Puglisi Fabio

机构信息

Treviglio Hospital, ASST-Bergamo Ovest, Treviglio, Italy.

Papa Giovanni XXIII Hospital, Bergamo, Italy.

出版信息

J Geriatr Oncol. 2019 Nov;10(6):990-993. doi: 10.1016/j.jgo.2019.05.003. Epub 2019 May 13.

DOI:10.1016/j.jgo.2019.05.003
PMID:31097340
Abstract
摘要

相似文献

1
Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study.甲磺酸艾瑞布林用于老年局部晚期或转移性乳腺癌患者的可行性：ESEMPiO研究的事后分析
J Geriatr Oncol. 2019 Nov;10(6):990-993. doi: 10.1016/j.jgo.2019.05.003. Epub 2019 May 13.
2
Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer.艾日布林用于“真实世界”中老年转移性乳腺癌患者的安全性与疗效
J Geriatr Oncol. 2018 May;9(3):281-283. doi: 10.1016/j.jgo.2017.11.003. Epub 2017 Nov 22.
3
Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.甲磺酸艾日布林作为三线或后线化疗用于局部复发或转移性老年乳腺癌患者：GIOGer（意大利老年肿瘤学组）-ERIBE 的多中心观察性研究。
Oncologist. 2019 Jun;24(6):e232-e240. doi: 10.1634/theoncologist.2017-0676. Epub 2018 Nov 9.
4
Eribulin mesylate in advanced breast cancer: retrospective review of a single institute experience.甲磺酸艾瑞布林治疗晚期乳腺癌：单机构经验回顾性分析
Future Oncol. 2015;11(15 Suppl):31-6. doi: 10.2217/fon.15.151.
5
Eribulin mesylate (Halaven) for breast cancer.甲磺酸艾瑞布林（海乐卫）用于治疗乳腺癌。
Med Lett Drugs Ther. 2011 Apr 18;53(1362):30-1.
6
Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancer.甲磺酸艾瑞布林在经治转移性乳腺癌患者中的安全性和耐受性
Am J Health Syst Pharm. 2015 Dec 15;72(24):2150-6. doi: 10.2146/ajhp140773.
7
Eribulin, Child-Pugh score, and liver-function tests: lessons from pivotal breast cancer studies 301 and 305.艾立布林、Child-Pugh 评分和肝功能检查：来自关键性乳腺癌研究 301 和 305 的经验教训。
Breast Cancer Res. 2021 Mar 18;23(1):33. doi: 10.1186/s13058-021-01407-w.
8
Eribulin in the treatment of advanced breast cancer: real-world scenario from 39 Italian centers - ESEMPiO study.艾立布林治疗晚期乳腺癌的真实世界研究：来自 39 家意大利中心的数据 - ESEMPiO 研究。
Future Oncol. 2019 Jan;15(1):33-44. doi: 10.2217/fon-2018-0324. Epub 2018 Nov 9.
9
Effect of eribulin on patients with metastatic breast cancer: multicenter retrospective observational study in Taiwan.艾立布林治疗转移性乳腺癌患者的效果：台湾多中心回顾性观察性研究。
Breast Cancer Res Treat. 2018 Aug;170(3):583-591. doi: 10.1007/s10549-018-4778-y. Epub 2018 Apr 5.
10
Eribulin-induced liver dysfunction as a prognostic indicator of survival of metastatic breast cancer patients: a retrospective study.艾日布林所致肝功能障碍作为转移性乳腺癌患者生存的预后指标：一项回顾性研究
BMC Cancer. 2016 Jul 7;16:404. doi: 10.1186/s12885-016-2436-5.

引用本文的文献

1
Breast Cancer in Geriatric Patients: Current Landscape and Future Prospects.老年患者乳腺癌：现状与未来展望。
Clin Interv Aging. 2022 Sep 28;17:1445-1460. doi: 10.2147/CIA.S365497. eCollection 2022.